Pronota is using its unique capabilities in exploring the proteomes of biological samples to build a portfolio of diagnostic products that work by analysing protein biomarkers.
Some of these products will be designed to help detect disease at its early and most treatable stage, and others to determine the best treatment for individual patients.
Pronota NV
VIB Bio-Incubator
Technologiepark 4
B-9052 Zwijnaarde / Ghent
Belgium
tel. +32 (0)9 241 11 64
fax. +32 (0)9 241 11 69
email. info@pronota.com
Latest News
Pronota awarded EUR 1.4 million grant to validate and develop novel cardiovascular biomarkers